Author

Maryam Fouladi

Nationwide Children's HospitalORCID 0000-0002-5693-035XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1

Frequent Co-Authors

Banlanjo Abdulaziz UmaruiD· 3 shared Rachid DrissiiD· 3 shared Shiva Senthil KumariD· 2 shared Ambuj KumariD· 1 shared Andrew BondociD· 1 shared Annie HuangiD· 1 shared Archana Mahadevan Iyer· 1 shared Arzu Onar-Thomas· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

Banlanjo Abdulaziz UmaruORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Integrated Multi-Omics Identifies Lineage-Dependent Myeloid Cells Recruitment and the APP-CD74 Axis as an Immunoregulatory Target in Pediatric High-Grade Glioma

Zhuang Wang, Ambuj Kumar, Banlanjo Abdulaziz Umaru, Archana Mahadevan Iyer, Komal Khan, Hao-Han Pang, Maryam Fouladi, Rachid Drissi

Acta Neuropathologica · Sep 22, 2026Peer-reviewedImmunology

hTERT Expression, Regulation, and Prognostic Significance in Pediatric Medulloblastoma

Ryuma Tanaka, Banlanjo Abdulaziz Umaru, Matthew Sobo, Shiva Senthil Kumar, Kathleen McCarthy O'Toole Dorris, Volker Hovestadt, Vijay Ramaswamy, Marc Remke, Ashley Margol, Charles B. Stevenson, Shahab Asgharzadeh, Stewart Goldman, Lili Miles, Jie Huang, Katja von Hoff, , Rachid Drissi

This study examines hTERT expression and its prognostic impact in pediatric medulloblastoma, finding higher expression correlates with worse survival outcomes.

bioRxiv · May 6, 2026 · PreprintCancer Biology

Efficacy of DNA Methyltransferase Inhibitor Immune Priming Therapy in Combination with PD-1 Inhibitors to Treat High-Risk Pediatric Brain Tumors

Deepak Kumar Mishra, Shelli M. Morris, Dean Popovski, Emily J. Girard, Andrew Bondoc, Shiva Senthil Kumar, Augusto Faria Andrade, Xiaoting Zhu, Fupan Yao, Mi‐Youn Brusniak, Banlanjo Abdulaziz Umaru, Erin E. Crotty, Kenneth Brasel, Fiona J. Pakiam, Caterina Russo, , Rachid Drissi

This study investigates the combination of DNA methyltransferase inhibitor decitabine and PD-1 inhibitor in high-risk pediatric brain tumor models, finding improved survival in some subtypes.

bioRxiv · May 14, 2025 · PreprintImmunology